Moberg Pharma AB (publ) (STO:MOB)

Sweden flag Sweden · Delayed Price · Currency is SEK
9.01
-0.09 (-1.04%)
At close: Dec 5, 2025
-44.00%
Market Cap 423.24M
Revenue (ttm) 12.50M
Net Income (ttm) -257.79M
Shares Out 47.00M
EPS (ttm) -5.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,153
Average Volume 86,703
Open 8.50
Previous Close 9.10
Day's Range 8.50 - 9.19
52-Week Range 6.34 - 16.46
Beta 1.08
RSI 51.33
Earnings Date Nov 11, 2025

About Moberg Pharma AB

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden. [Read more]

Sector Healthcare
Founded 2006
Employees 10
Stock Exchange Nasdaq Stockholm
Ticker Symbol MOB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.